Completed PHASE4 INTERVENTIONAL NCT00361075

Midlife Cholesterol Study

Mentored Patient Oriented Research Career Development Award

Sponsor: Northwestern University

Conditions Cardiovascular Disease Menopause Postmenopause Premenopause

Interventions transdermal estradiol patch (Vivelle), oral estrogen (Estrace), progesterone (Prometrium)

Updated 5 times since 2017 Last updated: Nov 4, 2014 Started: Jul 31, 1998 Completion: May 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Cardiovascular Disease and Menopause, this trial is completed. The trial is conducted by Northwestern University and has accumulated 5 data snapshots since 1998. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jul 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Northwestern University
University of Washington

Data source: Northwestern University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chicago, United States
• Seattle, United States